AI 检索
AI 阅读
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Supplementary Table S3 from Phase I Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Progressing on Enzalutamide

Wassim Abida,Andrew W. Hahn,Neal Shore,Neeraj Agarwal,Paul Sieber,Matthew R. Smith,Tanya Dorff, Paul Monk, Matthew Rettig,Rupal Patel, Anne Page, Maureen Duff,Rongda Xu,Jian Wang,Shravani Barkund,Aleksandr Pankov, Amber Wang,Melissa R. Junttila,Pratik S. Multani,Anneleen Daemen,Edna Chow Maneval, Christopher J. Logothetis,Michael J. Morris

crossref（2024）

引用 0|浏览2
暂无评分
摘要

Supplementary Table 3. Key Tumor Characteristics (AR Resistance Variants, AVPC Molecular Features, and GR Status) of Patients in Dose Expansion

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要